What is Cat Vaccines Market?
A vaccine is basically a biological preparation that hereby provides an actively acquired immunity to a specific kind of disease. A vaccine contains an agent that thereby resembles a disease-causing microorganism and is thus very often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins. Cat vaccines are the form of vaccines that are specifically used for cats.
The market study is being classified by Type (Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines and Recombinant Vaccines), by Application (Veterinary Hospitals, Veterinary Clinics and Animal Care Centers) and major geographies with country level break-up.
Bayer Healthcare (Germany), Vetoquinol S.A (France), Boehringer Ingelheim (Germany), Ceva (United States), Eli Lilly and Company (United States), Heska Co. (United States), Merck Animal Health (United States), Merial (Sanofi) and Virbac SA (France) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Zoetis (Pfizer) (United States).
The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that European Players will contribute to the maximum growth of Global Cat Vaccines market throughout the predicted period.
Analyst at AMA have segmented the market study of Global Cat Vaccines market by Type, Application and Region.
On the basis of geography, the market of Cat Vaccines has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- The Increase in the Companion Animal Population
- Rising Incidence of Zoonotic Diseases
- The Rising Demand for Animal-Derived Food Products
- Increasing Awareness Regarding Safe Animal Healthcare Practices
- Rising Pet Population Coupled With the Rising Awareness Regarding Their Health
- The High Storage Cost of Vaccines
- Initiatives by Various Government Agencies and Animal Associations to Maintain Animal Health
- The Constant R&D In Order To Develop Novel Vaccination Solutions
- Lack of Awareness in Less Developed Regions
Market Leaders and some development strategies
In 2020, Merck Animal Health signed a partnership agreement with Automazioni VX, Inc. (USA). This partnership was hereby done with an aim to introduce Innoject Pro, which was a newly developed subcutaneous vaccination technology for chicks. The technology is used in combination with Merck Animal Health's Innovax range of vaccines, which are used to protect against infectious diseases in poultry.
Key Target AudienceManufacturers of Cat Vaccines, Suppliers and Distributors of Cat Vaccines, Potential Investors, Market Research Firms, Regulatory Bodies, End-Users and Others
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase